Pralidoxime Chloride

Pralidoxime chloride

Pralidoxime chloride has its most critical effect in relieving paralysis of the
muscles of respiration.

CAS Number51-15-0
Molecular FormulaC7H9ClN2O
Molecular Weight172.61
InChI KeyHIGSLXSBYYMVKI-UHFFFAOYSA-N
Synonyms
  • 2-PAM chloride
  • 51-15-0
  • ComboPen
  • Protopam chloride
  • Pralidoxine chloride
  • Protopam
  • Pralidoxime (chloride)
  • Pyridine-2-aldoxime methochloride
  • Pyridinium aldoxime methochloride
  • 2-Pyridine aldoxime methyl chloride
  • N-Methylpyridine-2-aldoxime chloride
  • 2-Pyridine-aldoxime chloride
  • Pralidoxime chloride [USAN]
  • N-Methylpyridinium chloride 2-aldoxime
  • N-Methylpyridinium-2-aldoxime chloride
  • UNII-38X7XS076H
  • 1-Methyl-2-pyridinium aldoxime chloride
  • 1-Methyl-2-aldoximinopyridinium chloride
  • 2-Formyl-1-methylpyridinium chloride oxime
  • 2-Formyl-N-methylpyridinium oxime chloride
  • 2-PAM
  • EINECS 200-080-9
  • 2-Hydroxyiminomethyl-1-methylpyridinium chloride
  • N-Metylpyridinium-2-aldoxime chloride
  • NSC 164614
  • 1-Methyl-2-formylpyridinium chloride oxime
  • MLS000028727
  • CHEBI:8355
  • 38X7XS076H
  • 2-(Hydroxyiminomethyl)-1-methylpyridinium chloride
  • NSC-164614
  • Pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, chloride
  • SMR000059189
  • DSSTox_CID_3495
  • Pralidoxime chloride (USP)
  • Pralidoxime chloride [USP]
  • DSSTox_RID_77053
  • DSSTox_GSID_23495
  • Pyridinium, 2-formyl-1-methyl-, chloride, oxime
  • 2-Pyridinealdoxime methochloride
  • Q-201609
  • 2-[(E)-(hydroxyimino)methyl]-1-methylpyridinium chloride
  • NSC164614
  • Pralidoximchlorid
  • Pralidoximechloride
  • Pralidoxime chloride [USAN:USP]
  • Protopam (TN)
  • Pralidoxime (INN)
  • Pam 2Cl
  • 2-PAM (chloride)
  • AC1NSDWQ
  • Opera_ID_228
  • AC1Q1RUT
  • CAS-51-15-0
  • 2-PAM-Cl
  • NCGC00016226-01
  • C7H9N2O.HCl
  • Pralidoxime chloride [MI]
  • Pyridinium, chloride, oxime
  • SCHEMBL61419
  • 2-[(1E)-(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride
  • MLS001076535
  • MLS002222315
  • MLS003876809
  • Pralidoxime chloride [VANDF]
  • 2-[(hydroxyimino)methyl]-1-methylpyridinium chloride
  • Pralidoxime chloride [MART.]
  • Pralidoxime chloride [USP-RS]
  • Pralidoxime chloride [WHO-DD]
  • SCHEMBL1650343
  • DTXSID1023495
  • MolPort-004-440-359
  • HMS1570N08
  • HMS2097N08
  • HMS3259I04
  • HMS3714N08
  • Pharmakon1600-01505449
  • WLN: T6KJ A1 B1UNQ &G
  • 14018-50-9
  • Atnaa component pralidoxime chloride
  • HY-B1200
  • Pralidoxime chloride [GREEN BOOK]
  • Tox21_110316
  • MFCD00011981
  • NSC759147
  • Pralidoxime chloride [ORANGE BOOK]
  • s4575
  • Duodote component pralidoxime chloride
  • AKOS001094374
  • Tox21_110316_1
  • CCG-220943
  • CS-4828
  • FCH2256196
  • MCULE-2476744627
  • NSC-759147
  • Pralidoxime chloride component of atnaa
  • RTR-018235
  • NCGC00178286-05
  • Pralidoxime chloride component of duodote
  • AK324432
  • AN-41590
  • AS-13850
  • BBV-34551052
  • CPD000059189
  • SAM002554924
  • 2-Formyl-L-methylpyridinium chloride oxime
  • LS-132536
  • TR-018235
  • ST50825032
  • EN300-50184
  • D00469
  • J10435
  • M-2760
  • A828463
  • (1-methyl-2-pyridinylidene)methyl-oxoammonium chloride
  • (hydroxyimino)(1-methyl(2-pyridyl))methane, chloride
  • 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride
  • [(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium chloride
  • [(E)-(1-methylpyridin-2-ylidene)methyl]-oxoazanium chloride
  • (1-methylpyridin-2-ylidene)methyl-oxidanylidene-azanium chloride
  • Pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, chloride (E)-
  • Pyridinium, 2-[(hydroxyimino)methyl]-1-methyl-, chloride (1:1)
  • Pralidoxime chloride, United States Pharmacopeia (USP) Reference Standard

Applications:

HPLC Separation of Mixture of Atropine, Atrolactic Acid and Pralidoxime Chloride

April 15, 2019

 

Condition
Column Primesep 200, 4.6×150 mm, 3 µm, 100A
Mobile Phase MeCN/H2O – 20/80%
Buffer Gradient H3PO4 – 0.1-0.3%, 10 min
Flow Rate 1.0 ml/min
Detection UV, 200 nm

 

Description
Class of Compounds
 Drug, Acid, Base, Hydrophilic, Hydrophobic, Ionizable, Vitamin, Supplements
Analyzing Compounds Atropine, Atrolactic Acid, Pralidoxime Chloride

 

Application Column

Primesep 200

The Primesep family of mixed-mode columns offers a wide variety of stationary phases, boasting unprecedented selectivity in the separation of a broad array of chemical compounds across multiple applications. Corresponding Primesep guard columns, available with all stationary phases, do not require holders. SIELC provides a method development service available to all customers. Inquire about our specially-tailored custom LC-phases for specific separations.

Select options
Application Analytes:
Atrolactic Acid
Atropine
Pralidoxime Chloride
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

HPLC Determination of Pralidoxime Chloride on Primesep 200 Column

April 15, 2019

HPLC Determination of Pralidoxime Chloride

 

Condition
Column Primesep 200, 4.6×150 mm, 3 µm, 100A
Mobile Phase MeCN/H2O – 20/80%
Buffer H3PO4 – 0.1%
Flow Rate 1.0 ml/min
Detection UV, 200 nm

 

Description
Class of Compounds
 Drug, Basic, Hydrophobic, Ionizable
Analyzing Compounds Pralidoxime Chloride

 

Application Column

Primesep 200

The Primesep family of mixed-mode columns offers a wide variety of stationary phases, boasting unprecedented selectivity in the separation of a broad array of chemical compounds across multiple applications. Corresponding Primesep guard columns, available with all stationary phases, do not require holders. SIELC provides a method development service available to all customers. Inquire about our specially-tailored custom LC-phases for specific separations.

Select options
Application Analytes:
Pralidoxime Chloride
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.